Nutritional status of persons with HIV infection, persons with HIV infection and tuberculosis, and HIV-negative individuals from southern India.
We compared the nutritional status of individuals with human immunodeficiency virus (HIV) infection alone, individuals with HIV infection and tuberculosis (after completion of antituberculosis treatment), and HIV-negative individuals and found that malnutrition, anemia, and hypoalbuminemia were most pronounced among HIV-positive patients with tuberculosis. Weight loss was associated with loss of fat in female patients and with loss of body cell mass in male patients.
Swaminathan
Soumya
S
Tuberculosis Research Centre, Chetpet, Chennai, India. doctorsoumya@yahoo.com
Padmapriyadarsini
C
C
Sukumar
B
B
Iliayas
Sheikh
S
Kumar
S Ramesh
SR
Triveni
C
C
Gomathy
P
P
Thomas
Beena
B
Mathew
Minnie
M
Narayanan
P R
PR
D017088:AIDS-Related Opportunistic Infections / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D000328:Adult; D000740:Anemia / Q000150:complications; D000995:Antitubercular Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001823:Body Composition; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000008:administration & dosage / Q000627:therapeutic use; D015658:HIV Infections / Q000150:complications*; D018023:HIV Seronegativity; D006801:Humans; D034141:Hypoalbuminemia / Q000150:complications; D007194:India; D007538:Isoniazid / Q000008:administration & dosage / Q000627:therapeutic use; D044342:Malnutrition / Q000150:complications*; D009752:Nutritional Status; D011718:Pyrazinamide / Q000008:administration & dosage / Q000627:therapeutic use; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use; D016896:Treatment Outcome; D014397:Tuberculosis, Pulmonary / Q000150:complications* / Q000188:drug therapy
D000995:Antitubercular Agents; D011718:Pyrazinamide; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin